Acutus Medical, Inc.

AFIB Healthcare Medical Devices

In the quarter to December 2024, revenue grew 204.2%, EPS grew 95.9% and free cash flow grew 76.4%, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for three.

0.00 0.00 NaN
Market cap
$1.7M
P/E
0.0×
Fwd P/E
−0.5×
Dividend yield
—
F-score
3/9
Altman Z
−28.52
Beneish M
−2.49
Dividend safety
n/a
Dec '24 Sep '24 Jun '24 Mar '24 Older periods
Piotroski F-Score
3 — — 2

+8 more TTM periods

ROE
153.11% (391.52%) (254.45%) (237.28%)
ROA
(23.11%) (71.70%) (72.97%) (84.95%)
ROIC
(0.51%) (9.84%) (16.32%) (41.26%)
Return on Tangible Assets
(69.91%) (316.75%) (293.34%) (263.92%)
Average Days of Receivables
142.65 236.84 277.22 296.30
Free Cash Flow per Share
(1.07) (1.50) (1.87) (2.18)
Free Cash Flow
(31.77) (44.79) (55.51) (64.62)
Capital Expenditures
(0.11) 0.82 0.42 (0.30)
Other line items
Cash ROIC
(90.79%) (129.28%) (136.36%) (127.81%)
Accounts Receivable Turnover
2.10 1.62 1.44 1.46
Accounts Payable Turnover
9.48 4.80 3.84 2.71
Inventory Turnover
6.31 1.56 1.32 1.14
Average Days of Payables
24.33 40.21 44.55 97.53
Days of Inventory on Hand
34.13 98.49 138.00 181.44
Tax Rate
0.00 0.00 0.00 0.00
Research and Development Expense of Revenue
0.00% 10.59% 20.92% 0.00%
Selling, General and Administrative Expense of Revenue
51.77% 77.06% 97.67% 135.45%
Share Based Compensation of Revenue
2.28% 14.44% 19.25% 27.74%
Interest Coverage
(0.01) (0.25) (0.62) (1.21)
Operating CF/Net income
3.32 1.09 1.13 0.96
Depreciation/Fixed assets
3.73 1.80 1.31 0.61
Capex/Depreciation
(0.06) 0.62 0.39 (0.59)
Revenue per Share
0.68 0.52 0.41 0.32
Operating CF per Share
(1.06) (1.53) (1.88) (2.17)
Capex per Share
0.00 0.03 0.01 (0.01)
Capex to Sales
0.01 (0.05) (0.03) 0.03

Fold the line items

Columns are period end dates